Biohaven Pharmaceutical Holding Company Ltd.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 57.87 | -100% | -6.08 | -100% |
| P/S |
|
13.12 | 4.07 | 222.69% |
|
|
| P/BV |
|
7.2 | 9.39 | -23.35% |
|
|
| P/FCF |
|
-3.94 | 46.57 | -108.47% |
|
|
| Ev/Ebitda |
|
-6.62 | 17.62 | -137.54% |
|
|
| Ev/S |
|
3.88 | 4.37 | -11.15% |
|
|
| Ev/FCF |
|
-8.55 | 54.58 | -115.67% |
|
|
| E/P |
|
-0.3092 | 0.2164 | -242.87% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-70.8 | 20.15 | -451.4% | -328.18 | -78.43% |
| ROE |
|
-95.37 | -80.86 | 17.95% |
|
|
| ROA |
|
-79.53 | 6.71 | -1284.55% |
|
|
| ROIC |
|
0 | 15.68 | -100% |
|
|
| ROS |
|
-55.34 | 10.56 | -624.3% |
|
|
| ROCE |
|
-101.89 | 18.05 | -664.43% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0714 | 2.87 | -102.48% | -0.6328 | -88.72% |
| Nеt Debt/Ebitda |
|
0.5058 | 3.69 | -86.31% |
|
|
| Debt/Ratio |
|
0.0602 | 0.2643 | -77.24% |
|
|
| Debt/Equity |
|
0.0526 | 4.83 | -98.91% |
|
|
| Debt/Net Income |
|
-0.0756 | 6.45 | -101.17% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 1.31 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 6.4 | -100% | ||
| DSI |
|
0 | 0.7399 | -100% |
|
|
| Average dividend growth |
|
0 | -2.86 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 1.3 | -100% |
|
|
| Average percentage for payments |
|
0 | 77.61 | -100% |
|
|
| Difference from average difference in sector |
|
-1.31 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
622.66 | 362.86 | 71.6% | ||
| Growth impulse Ebitda in 5 years |
|
-18.69 | 373.75 | -105% | ||
| Growth impulse Net Income in 5 years |
|
-22.84 | 454.84 | -105.02% | ||
| Growth impulse FCF in 5 years |
|
-12.13 | 306.17 | -103.96% | ||
| Growth impulse EPS in 5 years |
|
-47.46 | 455.99 | -110.41% |
IP Score
3.14/10
